General Surgery

20 learning units • 100 chapter sections • 200 explained questions. Assess surgical disease, recognise complications and connect intervention with safe recovery and follow-up.

Original RAHBAR study material for the Year 4 learning pathway. Clinical cases support supervised undergraduate learning. Treatment choices, doses and procedures must follow current local protocols and the responsible clinical team. References & further reading ↓

MODULE 15 / 20

Breast Lumps & Breast Cancer Pathways

Use concordant clinical, imaging and tissue assessment while distinguishing infection from persistent suspicious disease.

Answer all 10 questions, then submit to see your score and explanations. This is a self-study exercise; results are not saved.

Question 01. What are the components of triple assessment? A. Three blood countsB. Mammography on three dates aloneC. Examination by three relativesD. Clinical examination, imaging and tissue assessment

Question 02. Does breast pain prove a lump is benign? A. YesB. NoC. Only during menstruation in every caseD. Yes, if the patient is young

Question 03. A biopsy is benign but imaging remains highly suspicious. What is needed? A. Discharge automaticallyB. Ignore the imagingC. Review concordance and consider further samplingD. Treat only anxiety

Question 04. What can ultrasound help identify in an inflamed breast? A. Every distant metastasisB. Receptor status directlyC. Exact response to all future treatmentD. A drainable abscess

Question 05. Persistent breast inflammation despite treatment should prompt what? A. Reassessment for abscess, alternative infection or malignancyB. Indefinite identical antibioticsC. Reassurance without examinationD. No follow-up if fever settles

Question 06. Why can core biopsy be useful in suspected cancer? A. It replaces all imagingB. It establishes every metastatic siteC. It provides tissue architecture and potential biomarker assessmentD. It always removes the whole tumour

Question 07. What influences breast-conserving surgery versus mastectomy? A. Tumour and breast factors, treatment options and patient preferencesB. Lump size alone in every caseC. Age aloneD. Pain intensity alone

Question 08. Why document the exact lump location? A. To replace consentB. To avoid all tissue testingC. To determine chemotherapy doseD. To ensure clinical, imaging and sampling findings refer to the same lesion

Question 09. Which is a relevant continuing-care issue after breast treatment? A. Only the original lump diameterB. No concern once the incision closesC. Avoiding discussion of body imageD. Arm symptoms and possible lymphoedema

Question 10. What advice is appropriate after a concordant benign assessment? A. Never seek review againB. Return if the lesion changes or symptoms persist unexpectedlyC. Assume every future lump is identicalD. Ignore new nipple changes

0 / 10 answered

References & Further Reading

Read the relevant guideline sections alongside these original clinical teaching cases. Local pathways, available services and individual patient factors determine care.

Reference review: 27 September 2026. Consult current local protocols for prescribing, procedures and escalation.